Different infusion durations for preventing platinum‐induced hearing loss in children with cancer
Information
- DOI:
- https://doi.org/10.1002/14651858.CD010885Copy DOI
- Database:
-
- Cochrane Database of Systematic Reviews
- Version published:
-
- 17 December 2013see what's new
- Type:
-
- Intervention
- Stage:
-
- Protocol
- Cochrane Editorial Group:
-
Cochrane Childhood Cancer Group
- Copyright:
-
- Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Article metrics
Altmetric:
Cited by:
Authors
Sources of support
Internal sources
-
Dutch Cochrane Centre, Netherlands.
External sources
-
Stichting Kinderen Kankervrij (KiKa), Netherlands.
Declarations of interest
None known
Acknowledgements
We thank Edith Leclercq for her help with developing the search strategies for the different databases. We also thank Dr ACH de Vries (Department of Pediatric Oncology, Sophia Children’s Hospital/Erasmus Medical Center, Rotterdam, the Netherlands) and an undisclosed person who kindly agreed to peer review our protocol.
The editorial base of the Cochrane Childhood Cancer Group is funded by Stichting Kinderen Kankervrij (KiKa).
Version history
| Published | Title | Stage | Authors | Version |
| 2020 Jan 21 | Different infusion durations for preventing platinum‐induced hearing loss in children with cancer | Review | Jorrit W van As, Henk van den Berg, Elvira C van Dalen | |
| 2018 Jul 05 | Different infusion durations for preventing platinum‐induced hearing loss in children with cancer | Review | Jorrit W van As, Henk van den Berg, Elvira C van Dalen | |
| 2016 Aug 08 | Different infusion durations for preventing platinum‐induced hearing loss in children with cancer | Review | Jorrit W van As, Henk van den Berg, Elvira C van Dalen | |
| 2014 Jun 26 | Different infusion durations for preventing platinum‐induced hearing loss in children with cancer | Review | Jorrit W van As, Henk van den Berg, Elvira C van Dalen | |
| 2013 Dec 17 | Different infusion durations for preventing platinum‐induced hearing loss in children with cancer | Protocol | Jorrit W van As, Henk van den Berg, Elvira C van Dalen | |
Keywords
MeSH
Medical Subject Headings (MeSH) Keywords
- Antineoplastic Agents [*administration & dosage, adverse effects];
- Carboplatin [administration & dosage, adverse effects];
- Cisplatin [*administration & dosage, adverse effects];
- Drug Administration Schedule;
- Hearing Loss [chemically induced, *prevention & control];
- Neuroblastoma [*drug therapy];
- Organoplatinum Compounds [administration & dosage, adverse effects];
- Randomized Controlled Trials as Topic;
- Tinnitus [chemically induced, prevention & control];
Medical Subject Headings Check Words
Child; Humans;
